Small RNA-directed DNA elimination

the molecular mechanism and its potential for genome editing

Review (2021)
Author(s)

C.K.J.M.L. Bastiaanssen (TU Delft - BN/Chirlmin Joo Lab, Kavli institute of nanoscience Delft)

C. Joo (Kavli institute of nanoscience Delft, TU Delft - BN/Chirlmin Joo Lab)

Research Group
BN/Chirlmin Joo Lab
Copyright
© 2021 C.K.J.M.L. Bastiaanssen, C. Joo
DOI related publication
https://doi.org/10.1080/15476286.2021.1885208
More Info
expand_more
Publication Year
2021
Language
English
Copyright
© 2021 C.K.J.M.L. Bastiaanssen, C. Joo
Research Group
BN/Chirlmin Joo Lab
Issue number
11
Volume number
18
Pages (from-to)
1540-1545
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Transposable elements have both detrimental and beneficial effects on their host genome. Tetrahymena is a unicellular eukaryote that deals with transposable elements in a unique way. It has a separate somatic and germline genome in two nuclei in a single cell. During sexual reproduction, a small RNA directed system compares the germline and somatic genome to identify transposable elements and related sequences. These are subsequently marked by heterochromatin and excised. In this Review, current knowledge of this system and the gaps therein are discussed. Additionally, the possibility to exploit the Tetrahymena machinery for genome editing and its advantages over the widely used CRISPR-Cas9 system will be explored. While the bacterial derived CRISPR-Cas9 has difficulty to access eukaryotic chromatin, Tetrahymena proteins are adept at acting in a chromatin context. Furthermore, Tetrahymena based gene therapy in humans might be a safer alternative to Cas9 because the latter can trigger an immune response.